The ACME Laboratories Ltd. (DSE:ACMELAB)

The ACME Laboratories Revenue

The ACME Laboratories had revenue of 10.14B BDT in the quarter ending December 31, 2025, with 15.70% growth. This brings the company's revenue in the last twelve months to 38.86B, up 15.99% year-over-year. In the fiscal year ending June 30, 2025, The ACME Laboratories had annual revenue of 35.94B with 12.54% growth.

• Revenue (ttm): 38.86B
• Revenue Growth: +15.99%
• P/S Ratio: 0.41
• Revenue / Employee: 4.31M
• Employees: 9,025
• Market Cap: 16.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	35.94B	4.01B	12.54%
Jun 30, 2024	31.93B	4.98B	18.49%
Jun 30, 2023	26.95B	3.09B	12.95%
Jun 30, 2022	23.86B	3.09B	14.87%
Jun 30, 2021	20.77B	1.77B	9.30%